NetworkNewsAudio Archive - NetworkNewsWire

FridayAug 23, 2019 8:00 am

NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Making Headway in Clinical Program Expansion, Company Growth

Related Editorial Biotech and biopharma industry leaders are posting record financials and hitting milestone markers in their research and growth, good indicators of a strong market with potential for robust returns on investment. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) has completed key steps in its overall strategy to expand its clinical development programs and bring Oncoprex(TM) immunogene therapy, its lead drug candidate, to commercialization. Over the past five years, Amgen Inc. (NASDAQ: AMGN) has invested nearly $19 billion in R&D and, as a result, is now advancing a record number of clinical assets. Biogen Inc. (NASDAQ: BIIB) has added four new programs to…

ThursdayAug 15, 2019 8:00 am

NetworkNewsAudio – Grapefruit Boulevard Investments Inc. (IGNG) Interview

Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s cannabis and CBD extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 10 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January of 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis and CBD…

MondayAug 05, 2019 7:00 pm

NetworkNewsAudio – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Interview

A TSX Venture Top 50 Company, Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of cellular communications systems for enterprise customers, specializing in connected vehicle products for professional fleets, marketed under the Uniden® Cellular brand. Since developing the world’s first 3G connected vehicle device, Siyata has been a pioneer in the industry, launching the world’s first 4G LTE all-in-one fleet communications device in 2017. Incorporating voice, push-to-talk over cellular, data, and fleet management solutions into a single device, the company aims to become the connected vehicle communications device of choice for commercial vehicles and…

WednesdayJul 24, 2019 7:00 pm

NetworkNewsAudio – VPR Brands, LP (VPRB) Interview

VPR Brands LP (OTC: VPRB) is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market including e-liquids. Vaporizers and electronic cigarettes (also known as e-cigarettes) are devices that deliver nicotine and/or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information, visit the company’s website at www.VPRBrands.com. NOTE TO INVESTORS: The latest news and updates relating to VPRB are…

TuesdayJul 23, 2019 7:00 pm

NetworkNewsAudio – Golden Developing Solutions, Inc. (DVLP) Interview

Golden Developing Solutions (OTC: DVLP) is developing an online retail business for cannabidiol (CBD), hemp oil and health/wellness-related products. The company is also developing a high-capacity, high-quality CBD extraction and production facility. In addition, through wholesale and distribution channels, the company offers a broad range of high-quality, price-competitive products, including traditional vitamins; supplements; and CBD-based tinctures, vapes and soft gels, among other products. Merchandise also includes hemp and CBD-related products and additional products focusing on health and lifestyle. For more information, visit the company’s websites at www.GoldenDeveloping.com and www.WheresWeed.com. NOTE TO INVESTORS: The latest news and updates relating to DVLP…

MondayJul 22, 2019 12:10 pm

NetworkNewsAudio – Endonovo Therapeutics Inc. (ENDV) Interview

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders. For more information, visit the company’s website at http://endonovo.com NOTE TO INVESTORS: The latest news and updates relating to ENDV are available in the company’s newsroom at http://nnw.fm/ENDV About NetworkNewsAudio NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit…

WednesdayJul 17, 2019 8:00 pm

NetworkNewsAudio – ORHub Inc. (ORHB) Interview

ORHub (OTC: ORHB) is a growth stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power in their data captured in the OR. Surgical Spotlight(R) helps providers harness that data, identify millions of dollars in opportunities, and get leaders back to their primary focus: improving care, increasing patient access and reducing costs. A first-of-kind team building tool brings all stakeholders together with regular and accessible information. ORHub specializes in business intelligence for the operating room, built by…

MondayJul 15, 2019 6:00 pm

NetworkNewsAudio – MustGrow Biologics Corp. (CSE: MGRO) Interview

MustGrow Biologics Corp. (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented natural biologic product that acts as a pesticide, fungicide nematicide and fertilizer. Targeting the fruit, vegetable, turf, ornamentals and cannabis industries, MustGrow has designed a United States EPA-approved organic solution that uses the mustard seed’s natural defense mechanisms to protect plants from pests and diseases. Approximately $9 million has previously been spent on 110 independent tests, validating MustGrow’s remarkably safe and effective granular product. MustGrow’s granular product is EPA-approved across all key U.S. states as a fertilizer and pesticide (currently limited to fertilizer…

FridayJun 14, 2019 8:00 am

NetworkNewsAudio – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Employs Aggressive Exploration and Development Program Amid Surging Nickel Demand

Related Editorial Growth in demand for batteries is pushing up nickel production and economic change in Indonesia. Nickel is an essential component in batteries, including those for cars and phones. Demand for metals is growing, most importantly in China, a major battery manufacturer. Indonesia is the world’s largest nickel producer. The country is working to expand its manufacturing sector, attracting investment from multinational industry and mining giants. Pacific Rim Cobalt Corporation (OTCQB: PCRCF) (CSE: BOLT) (PCRCF Profile) is making the most of Indonesian nickel through an aggressive exploration and development program there. VALE S.A. (NYSE: VALE), the world’s leading nickel…

MondayJun 10, 2019 6:30 pm

NetworkNewsAudio – INmune Bio Inc. (NASDAQ: INMB) Interview

About INmune Bio Inc. INmune Bio Inc. (NASDAQ: INMB) is a clinical-stage biotechnology company developing therapies targeting the innate immune system to fight disease. INmune Bio is developing three product platforms: two products that reengineer the patient’s innate immune system’s response to cancer and one product to treat neuroinflammation that is currently focused on Alzheimer’s disease. INKmune is a natural killer (“NK”) cell therapeutic that primes the patient’s NK cells to attack minimal residual disease, the remaining cancer cells that are difficult to detect, which often cause relapse. INB03 inhibits myeloid derived suppressor cells (“MDSC”), which often cause resistance to immunotherapy,…